1. Case series of docetaxel, trastuzumab, and pertuzumab (DTP) as first line anti-HER2 therapy and ado-trastuzumab emtansine (T-DM1) as second line for recurrent or metastatic HER2-positive salivary duct carcinoma. (February 2022) Authors: Uijen, M.J.M.; Lassche, G.; van Engen-van Grunsven, A.C.H.; Driessen, C.M.L.; van Herpen, C.M.L. Journal: Oral oncology Issue: Volume 125(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Chemotherapy and radiotherapy in locally advanced head and neck cancer: an individual patient data network meta-analysis. Issue 5 (May 2021) Authors: Petit, Claire; Lacas, Benjamin; Pignon, Jean-Pierre; Le, Quynh Thu; Grégoire, Vincent; Grau, Cai; Hackshaw, Allan; Zackrisson, Björn; Parmar, Mahesh K B; Lee, Ju-Whei; Ghi, Maria Grazia; Sanguineti, Giuseppe; Temam, Stéphane; Cheugoua-Zanetsie, Maurice; O'Sullivan, Brian; Posner, Marshall R; Voke... Journal: Lancet oncology Issue: Volume 22:Issue 5(2021) Page Start: 727 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Induction chemotherapy with docetaxel/cisplatin/5-fluorouracil followed by randomization to two cisplatin-based concomitant chemoradiotherapy schedules in patients with locally advanced head and neck cancer (CONDOR study) (Dutch Head and Neck Society 08-01): A randomized phase II study. (January 2016) Authors: Driessen, C.M.L.; de Boer, J.P.; Gelderblom, H.; Rasch, C.R.N.; de Jong, M.A.; Verbist, B.M.; Melchers, W.J.G.; Tesselaar, M.E.T.; van der Graaf, W.T.A.; Kaanders, J.H.A.M.; van Herpen, C.M.L. Journal: European journal of cancer Issue: Volume 52(2016) Page Start: 77 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Systemic therapy in the management of recurrent or metastatic salivary duct carcinoma: A systematic review. (September 2020) Authors: Uijen, M.J.M.; Lassche, G.; van Engen-van Grunsven, A.C.H.; Tada, Y.; Verhaegh, G.W.; Schalken, J.A.; Driessen, C.M.L.; van Herpen, C.M.L. Journal: Cancer treatment reviews Issue: Volume 89(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Using a semi‐conductor sequencing‐based panel for genotyping of HPV‐positive and HPV‐negative oropharyngeal cancer: a retrospective pilot study. (8th January 2017) Authors: Ham, J.C.; Tops, B.B.J.; Driessen, C.M.L.; van Raaij, A.W.M.; Slootweg, P.J.; Melchers, W.J.G.; Ligtenberg, M.J.L.; van Herpen, C.M.L. Journal: Clinical otolaryngology Issue: Volume 42:Number 3(2017:Jun.) Page Start: 681 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗